A Summary of our Adapt or Die Meeting, held in December 2016: “Military and Health Care Systems & Strategic Decision Making”.
Length: 19 pages (PDF)
Target Audience: BioPharma, Payers, Suppliers
The Zensights Adapt or Die conferences are becoming known for high-level pharmaceutical leaders and their peers to gather to discuss effective leadership issues, whether on the battlefield or in the boardroom.
Much of the focus on effective leadership and decision-making was geared to better understand how America’s Veterans are coping as they return to civilian life.
“What decisions can the pharmaceutical industry make now that will help our veterans recover from the perils of combat? Some vets are able to make a smooth transition stateside, others have physical issues that require rigorous recovery efforts due to lost limbs and other physical carnage and yet many vets suffer in silence due to the trauma the men and women of our great nation experienced first-hand while on deployment..”
Leading this dialog was Retired US Army Lieutenant General Rick Lynch who has first hand combat experience in Iraq as he led the task Force Marne for 15 months.
The connection with the pharmaceutical industry is very simple as many of their products treat Post Traumatic Stress (PTS) and Traumatic Brain Injury (TBI), which are the leading symptoms of the Invisible Wounds of War.
This initiative also closely aligns with the mission of the Bush Institute, where the conference was held in Dallas, TX.
President George W. Bush (43) also addressed the group and he shared how he has dedicated the rest of his life helping the post 9/11 veterans of our country to become more productive members of society.
Read the Meeting Summary & Recommendations for the event held on April 27th, 2017 in West Point, NY.